|
Company: AscellaHealth, Berwyn PA
Nomination Submitted by: CPR Strategic Communications
Company Description: AscellaHealth is a global Specialty Pharmacy and Healthcare services organization serving payers, providers, life sciences and patients, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services.
Nomination Category: Company / Organization Categories
Nomination Sub Category: Company of the Year - Pharmaceuticals - Small
 Nomination Title: AscellaHealth
- Which will you submit for your nomination in this category, a video of up to five (5) minutes in length about the achievements of the nominated organization since January 1 2020, OR written answers to the questions for this category? (Choose one):
Written answers to the questions
- If you are submitting a video of up to five (5) minutes in length, provide the URL of the nominated video here, OR attach it to your entry via the "Add Attachments, Videos, or Links to This Entry" link above, through which you may also upload a copy of your video.
- If you are providing written answers for your submission, you must provide an answer to this first question: Briefly describe the nominated organization: its history and past performance (up to 200 words):
Total 188 words used.
AscellaHealth is a global Specialty Pharmacy and Healthcare services organization serving patients, payers, life sciences and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services. An Inc. 5000 2021 winner, AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies.
AscellaHealth shifted from a pharmacy benefit management organization to a leading strategic Specialty Pharmacy solutions provider. AscellaHealth has grown into a $140M premier provider of Specialty Pharmacy and Healthcare services with a 768% 4-year revenue growth and several accolades recognizing its business and social impact achievements.
AscellaHealth grew services in 2021 to include a comprehensive suite of SP services for Life Sciences, including pre-commercialization, outsourced market access, wholesale, 3PL, limited distribution drug fulfillment, and custom Patient Support and HUB Services to enhance patient access to high-cost specialty pharmaceuticals. Other services improving patient health outcomes include compliance/persistency programs, innovative financial solutions and a suite of payer services that manage specialty spend and reduce costs.
- If you are providing written answers for your submission, you must provide an answer to this second question: Outline the organization's achievements since the beginning of 2020 that you wish to bring to the judges' attention (up to 250 words):
Total 227 words used.
- 2020 – ‘Soaring 76’ list #6
- 2020 – Philadelphia 100 list #7
- 2021 – Inc. Magazine’s 5000 Fastest Growing Companies list #1,208
- 2021 – Philadelphia 100 list #36
- 2021 – Top Workplaces nominee
- 2021 – CEO honored as one of the most admired CEOs in Greater Philadelphia
- 2021 – Deloitte Fast 500 list #299
- 2021 – Achieved 768% 4-year growth
- 2021 – Distributes digital educational newsletter monthly, “Developments in Specialty Pharmacy” sharing spotlight articles on foundations dedicated to helping those with rare and orphan diseases and other Specialty Pharmacy news
- 2021 – Launched innovative, first-of-its-kind loan-based financial assistance program that eliminates barriers to accessing high-cost therapies and ensures members receive Specialty and gene/cell therapies they need, when they need them most, regardless of financial status
- 2021 – Redesigned website to emphasize expanded services for key market sectors and created a more robust, streamlined website
- 2021 – Forged strategic alliance with Optime Care, Inc., a nationally recognized specialty pharmacy, distribution and patient management organization to further expand patient-first services
- 2022 – AscellaHealth handpicked pharmacies for preferred status within Home Infusion Pharmacy Network including Walmart, Amber Specialty Pharmacy, AcariaHealth and BioMatrix Specialty Pharmacy
- 2022 – Inaugural Gene Therapy and Specialty Pharmacy Rx Awareness month (September), an observance founded by AscellaHealth and recognized by The Society for Health Care Strategy and Market Development, part of the American Hospital Association
- If you are providing written answers for your submission, you must provide an answer to this third question: Explain why the achievements you have highlighted are unique or significant. If possible compare the achievements to the performance of other players in your industry and/or to the organization's past performance (up to 250 words):
Total 243 words used.
AscellaHealth’s existing and new solutions are unparalleled in the market. The innovative and first-to-market services enable members to break down financial barriers to access treatment, including high-cost specialty medications and gene therapies; allow payers to enrich benefits and enable cost savings for novel therapies; support life science companies in their quest to ensure patients of all socioeconomic status have seamless access to specialty drugs; and arm providers with best-in-class programs to support patient care and enhance outcomes.
Expanded services including outsourced market access solutions, ensure successful product launches and adoption by making treatments more accessible and affordable. AscellaHealth is focused on providing custom solutions to pharmaceutical companies regardless of size or industry status. This expanded focus enables AscellaHealth to support a wider range of products and dominate the marketplace. State-of-the-art programs and services include:
- Pre-Commercialization & Market Access
- LDD Specialty Pharmacy Fulfillment
- Specialty Pharmacy & Medical Benefit Management
- Financial & Copay Assistance Programs
- Patient Support & HUB Services
- Group Purchasing Services & Drug Rebate Programs
AscellaHealth is a fast-growth company and its leading position in the marketplace allows the company to share several educational initiatives including “Developments in Specialty Pharmacy,” an industry newsletter sharing news from advocacy organizations, key industry updates and innovative solutions to contain costs for expensive Specialty therapies. AscellaHealth also hosts webinars and will sponsor the inaugural Gene Therapy and Specialty Pharmacy Rx Awareness. This month will focus on raising awareness for people living with rare and orphan diseases.
- You have the option to answer this final question: Reference any attachments of supporting materials throughout this nomination and how they provide evidence of the claims you have made in this nomination (up to 250 words):
Total 250 words used.
The attached press releases announce AscellaHealth’s milestones. These announcements demonstrate the company’s leadership and recognition in the marketplace.
Additionally, see recent articles in “Developments in Specialty Pharmacy.” These educational articles support Specialty Pharmacy and healthcare decision-making, highlight news in the industry and explain ways to contain costs for expensive cell and gene therapies.
- 340B Drug Pricing Program Draws Supporters and Critics
- FDA Approval of Biogen’s High-Cost Alzheimer’s Drug Highlights Need for Specialty Pharmacy Management
- Value-Based Insurance Design
- Muscular Dystrophy Association
|
